Title: Role of CT & MRI in the Imaging Spectrum of Central Nervous System Complications in Paediatric Leukemias
Authors: Dr Sumod Mathew Koshy MD FRCR, Dr Nikhil Gopinathan MBBS, Dr Neha Mohan MD, Dr Anil Prahladan DNB, EDiR, Dr Krishnankutty Nair Ramachandran MD
DOI: https://dx.doi.org/10.18535/jmscr/v5i3.133
Abstract
Leukemia is the most common childhood malignancy representing nearly 30% of all malignancies in children. With advances in treatment, prognosis and survival rates have vastly increased, resulting in a similar increase in the number of adverse effects and complications as well. There is an increased risk of CNS complications in acute leukemia either resulting from direct effects of leukemia or from antileukemic therapy. Bone marrow transplantation requires suppression of the recipient’s immune system and administration of cytotoxic drugs like cyclophosphamide. Early recognition of CNS complications is important, in order to ensure timely treatment and to avoid grave consequences, thereby improving the overall survival benefits. Most of the neurologic complications have similar overlapping clinical presentations resulting in a diagnostic dilemma. Here imaging, especially CT & MRI has a major role to play and helps to arrive at a reasonable diagnosis. This study retrospectively analyzed neuroimaging of 149 pediatric leukemic patients who underwent CT/MRI with a clinical suspicion of neurological complication. Of the 149 children, CT brain was done for 90 children, MRI brain was done for 40 children and 10 of them had both CT and MRI done. Positive findings were recorded in 44 children on CT and 24 children on MRI. The diverse pathologic entities that we came across in CT/MRI of these patients have been grouped into different categories. The major complications encountered were cerebrovascular complications including venous sinus thrombosis, intracranial haemorrhages and infarcts, CNS infections, leukaemic involvement, misclellaneous conditions like hydrocephalous and treatment complications. These included mainly, leukoencephalopathy, methotrexate related complications and PRES.
References
1. Pizzo PA, Poplack DG. Principles and Practice of Pediatric Oncology. Wolters Kluwer Health; 2015.
2. Ginsberg LE, Leeds NE. Neuroradiology of leukemia. Am J Roentgenol. 1995 Sep 1;165(3):525–34.
3. Kembhavi SA, Somvanshi S, Banavali S, Kurkure P, Arora B. Pictorial essay: Acute neurological complications in children with acute lymphoblastic leukemia. Indian J Radiol Imaging. 2012;22(2):98–105.
4. Vázquez E, Lucaya J, Castellote A, Piqueras J, Sainz P, Olivé T, et al. Neuroimaging in Pediatric Leukemia and Lymphoma: Differential Diagnosis. Radio Graphics. 2002 Nov 1;22(6):1411–28.
5. Ramsay NK, Coccia PF, Krivit W, Nesbit ME, Edson JR. The effect of L-asparaginase of plasma coagulation factors in acute lymphoblastic leukemia. Cancer. 1977 Oct;40(4):1398–401.
6. Guermazi A, Feger C, Rousselot P, Merad M, Benchaib N, Bourrier P, et al. Granulocytic Sarcoma (Chloroma). Am J Roentgenol. 2002 Feb 1;178(2):319–25.
7. Pui MH, Fletcher BD, Langston JW. Granulocytic sarcoma in childhood leukemia: imaging features. Radiology. 1994 Mar;190(3):698–702.
8. Ball WS, Prenger EC, Ballard ET. Neurotoxicity of radio/chemotherapy in children: pathologic and MR correlation. AJNR Am J Neuroradiol. 1992 Apr;13(2):761–76.
9. Fisher MJ, Khademian ZP, Simon EM, Zimmerman RA, Bilaniuk LT. Diffusion-weighted MR imaging of early methotrexate-related neurotoxicity in children. AJNR Am J Neuroradiol. 2005 Aug;26(7):1686–9.
10. Matsumoto K, Takahashi S, Sato A, Imaizumi M, Higano S, Sakamoto K, et al. Leukoencephalopathy in childhood hematopoietic neoplasm caused by moderate-dose methotrexate and prophylactic cranial radiotherapy—An MR analysis. Int J Radiat Oncol • Biol • Phys. 1995 Jul 15;32(4):913–8.
11. Gowan GM, Herrington JD, Simonetta AB. Methotrexate-Induced Toxic Leukoe-ncephalopathy. Pharmacother J Hum Pharmacol Drug Ther. 2002 Sep 1;22(9):1 183–7.
12. Antunes NL, Small TN, George D, Boulad F, Lis E. Posterior leukoencephalopathy syndrome may not be reversible. Pediatr Neurol. 1999 Mar;20(3):241–3.
Dr Sumod Mathew Koshy MD, FRCR
Division of Imageology, Regional Cancer Centre, Medical College Campus
Trivandrum, Kerala, India Pin 695011
Email: This email address is being protected from spambots. You need JavaScript enabled to view it., +91 471 252 2604, +91 9446810833